Louis Lange M.D., Ph.D. Net Worth & Insider Trades

Louis Lange M.D., Ph.D. - Director, Audentes Therapeutics, Inc

As of December 27, 2019

What is Louis Lange M.D., Ph.D.'s Net Worth?

The current estimated net worth of Audentes Therapeutics, Inc's Director, Louis Lange M.D., Ph.D., is estimated to be about $12.12M . Louis Lange M.D., Ph.D. owns about 17,233 units of Audentes Therapeutics, Inc common stock. In the last 3 years at Audentes Therapeutics, Inc, Louis Lange M.D., Ph.D. has sold an estimated value of $9.35M worth.

What is Louis Lange M.D., Ph.D.'s Past Insider Trading?

Louis Lange M.D., Ph.D.'s largest sale order was 48,000 units , worth over $1.39M on March 28, 2018. In total, Louis Lange M.D., Ph.D. has made about 18 transactions over 3 years of their time at Audentes Therapeutics, Inc. Louis Lange M.D., Ph.D. usually trades in June and September, with the busiest year in 2018. The most recent transaction was a sale order of 11,000 units , worth over $655.59K on December 27, 2019.

Louis G Lange

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Louis Lange M.D., Ph.D.'s' Mailing Address?

  • Mailing address is 3172 Porter Drive Palo Alto CA 94034 CA

What are Audentes Therapeutics, Inc's Past Insider Trades?

Audentes Therapeutics, Inc's most recent insider trade came on December 27, 2019 by Louis Lange M.D., Ph.D. who sold 11,000 units worth $655.59K . In the last 3 years, insiders at Audentes Therapeutics, Inc have sold an estimated value of $142.4M and bought an estimated value of $15.46M worth of shares. Insider trading is most common in January, with the busiest year in 2017. The most active traders at the company are Matthew Patterson, Chief Executive Officer,  Louis G Lange, Director,  and Suyash Prasad, Senior VP & Chief Med Officer .

Audentes Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1